Moderna takes first autoimmune therapeutic candidate into the clinic

Moderna takes first autoimmune therapeutic candidate into the clinic

Source: 
Biopharma Reporter
snippet: 

Moderna has dosed the first participant in a Phase 1 study of its IL-2 mRNA therapeutic, mRNA-6231.